| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/17/2010 | US20100150937 Antagonists of pcsk9 |
| 06/17/2010 | US20100150934 Botulinum antitoxin compositions and methods |
| 06/17/2010 | US20100150933 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 06/17/2010 | US20100150930 Mage-11 as a marker for endometrial receptivity to embryo transplantation and a marker and therapeutic target in castration-recurrent prostate cancer |
| 06/17/2010 | US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker |
| 06/17/2010 | US20100150927 Cell death inducer |
| 06/17/2010 | US20100150926 Fusion protein capable of binding vegf-a and tnf-alpha |
| 06/17/2010 | US20100150925 Treatment of b-cell cancers with anti-cd70 antibody-drug conjugates |
| 06/17/2010 | US20100150924 Regulation of myelination by nectin-like (necl) molecules |
| 06/17/2010 | US20100150923 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 06/17/2010 | US20100150922 Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus |
| 06/17/2010 | US20100150919 Crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 06/17/2010 | US20100150918 Cross-species-specific binding domain |
| 06/17/2010 | US20100150916 huTNFR1 Selective Antagonists |
| 06/17/2010 | US20100150914 Agonist trkb antibodies and uses thereof |
| 06/17/2010 | US20100150912 Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes |
| 06/17/2010 | US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION |
| 06/17/2010 | US20100150907 Pro115 antibody compositions and methods of use |
| 06/17/2010 | US20100150906 Antibodies |
| 06/17/2010 | US20100150905 Kim-1 antibodies for treatment of th2-mediated conditions |
| 06/17/2010 | US20100150904 Binding members for ige molecules |
| 06/17/2010 | US20100150902 Anti-cd151 antibodies and their use in the treatment of cancer |
| 06/17/2010 | US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 06/17/2010 | US20100150879 Methods for the detection, isolation, and use of lipid phosphate phosphatase-3-positive stem cells |
| 06/17/2010 | US20100150877 Osteopontin for the Prediction and Treatment of Cardiovascular Diseases |
| 06/17/2010 | US20100150864 Antibodies that bind to il-18 and methods of purifying the same |
| 06/17/2010 | US20100150837 ANTIBODIES AGAINST GPIb alpha |
| 06/17/2010 | CA2747244A1 Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis |
| 06/17/2010 | CA2746395A1 Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis |
| 06/17/2010 | CA2746334A1 Remedies for pemphigus containing anti fas ligand antibodies |
| 06/17/2010 | CA2746101A1 Human antibodies against tissue factor |
| 06/17/2010 | CA2745938A1 Antibody formulation |
| 06/17/2010 | CA2745849A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer |
| 06/17/2010 | CA2745492A1 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 06/17/2010 | CA2744754A1 Ige ch3 peptide vaccine |
| 06/17/2010 | CA2744512A1 Isoform specific anti-her4 antibodies |
| 06/17/2010 | CA2740341A1 Anti-igf antibodies |
| 06/16/2010 | EP2196541A1 Anti-glypican-3 antibody having improved kinetics in plasma |
| 06/16/2010 | EP2196476A1 Antibody formulation |
| 06/16/2010 | EP2196473A1 Mycobacterial antigens expressed during latency |
| 06/16/2010 | EP2196219A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 06/16/2010 | EP2196218A2 Use of anti-TNFalpha antibodies and another drug |
| 06/16/2010 | EP2195447A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
| 06/16/2010 | EP2195431A1 Methods for increasing protein titers |
| 06/16/2010 | EP2195347A1 Method for treating and diagnosing hematologic malignancies |
| 06/16/2010 | EP2195346A1 Dendritic cell marker and uses thereof |
| 06/16/2010 | EP2195345A2 Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods |
| 06/16/2010 | EP2195344A2 Novel compositions and methods for stimulating erythropoiesis in a mammal |
| 06/16/2010 | EP2195343A2 Method for the preparation of new oligoclonal antibodies |
| 06/16/2010 | EP2195341A1 Dual specificity antibody fusions |
| 06/16/2010 | EP2195339A2 A process for producing hepcidin |
| 06/16/2010 | EP2195028A2 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| 06/16/2010 | EP2195025A1 Therapeutic antibody purification method and method of use |
| 06/16/2010 | EP2195024A1 Method of inhibiting complement activation with factor bb specific antibodies |
| 06/16/2010 | EP2195023A1 Humanized anti-cxcr5 antibodies, derivatives thereof and their uses |
| 06/16/2010 | EP1560594B1 Antigenic compositions for immunization of non-human mammals against streptococcus equi |
| 06/16/2010 | CN1926146B Antibody purification |
| 06/16/2010 | CN1904034B Novel bacterium and vaccine |
| 06/16/2010 | CN1636019B Recombinant antibodies, and compositions and methods for making and using the same |
| 06/16/2010 | CN1487996B Transgenic transchromosomal rodents for making human antibodies |
| 06/16/2010 | CN1406249B Enhancing the circulating half-life of antibody-based fusion proteins |
| 06/16/2010 | CN1162978B Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 06/16/2010 | CN101743476A Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same |
| 06/16/2010 | CN101743256A an anti-cancer cytotoxic monoclonal antibody |
| 06/16/2010 | CN101743255A an anti-cancer cytotoxic monoclonal antibody |
| 06/16/2010 | CN101743254A Antigen binding proteins that bind PAR-2 |
| 06/16/2010 | CN101743251A Peptides with anitfungal activity |
| 06/16/2010 | CN101735989A Hybridoma cell for resisting URG11 monoclonal antibody |
| 06/16/2010 | CN101735988A Hybridoma cell for resisting URG4 monoclonal antibody |
| 06/16/2010 | CN101735987A Mouse monoclonal antibody cell strain for resisting amoxicillin and ampicillin |
| 06/16/2010 | CN101735986A Hybridoma cell strain secreting monoclonal antibodies against swine HEV and application thereof |
| 06/16/2010 | CN101735320A Yolk immunoglobulin for preventing and treating cryptosporidiosis andersoni |
| 06/16/2010 | CN101735319A Monoclonal antibody against GP73 protein, preparation method and application thereof |
| 06/16/2010 | CN101735318A Cell strain, monoclonal antibody and kit for detecting tobacco rattle virus |
| 06/16/2010 | CN101735317A Cathepsin D antigen polypeptide and application thereof as well as detecting kit containing polypeptide |
| 06/16/2010 | CN101735316A Application of SM22 antigen polypeptide and autoantibody in preparing tumor detection kit and detection kit containing polypeptide |
| 06/16/2010 | CN101735309A Iridovirus antigen active polypeptide and application thereof |
| 06/16/2010 | CN101732333A Medicament for treating cancer |
| 06/16/2010 | CN101731458A Yolk powder containing double-titer yolk antibody of anti-porcine CCK/Urease, and preparation method thereof |
| 06/16/2010 | CN101045161B Modulators of P-selectin glycoprotein ligand 1 |
| 06/15/2010 | US7737325 non-human knock-out mammal lacking alpha-1,6-fucosylation, comprising an exogenous gene encoding an antibodies comprising an Fc region bound to a complex N-glycoside-linked sugar chains comprising a reducing end which contains an N-acetylglucosamine |
| 06/15/2010 | US7737260 a protein conjugate comprising a physiologically active polypeptide, a non-peptide polymer and an immunoglobulin Fc fragment, with improved in vivo duration and stability; nonimmunogenic |
| 06/15/2010 | US7737259 antibodies that specifically binds to interleukin (IL-22), used for the diagnosis and treatment of inflammation and autoimmune disorders, such as psoriasis |
| 06/15/2010 | US7737258 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents |
| 06/15/2010 | US7737257 Connective tissue growth factor (CTGF-3) |
| 06/15/2010 | US7737256 anti-HIV action of uPAR-activators or activated uPAR molecules; diagnosis of cancer, AIDS and inflammatory diseases; treatment of septic shock, rheumatoid arthritis, Crohn's disease, and chronic arthritis |
| 06/15/2010 | US7737255 monoclonal antibodies used for analyzing changes in the levels of cancer specific genes in cells, tissues or bodily fluids; medical prognosis |
| 06/15/2010 | US7737254 Chimeric human T1R1 taste receptor polypeptides and compositions containing same |
| 06/15/2010 | US7737111 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases |
| 06/15/2010 | US7736874 Relicating preferential nucleotide sequences using mixture comprising polymerase-amplified nucleic acid having a 5' overhang, a vector having a 3' overhang and an antibody that binds polymerase; improving exogenous gene expression |
| 06/15/2010 | US7736873 An isolated nucleic acid molecule comprising a nucleotide sequence which encodes the polypeptide comprising the outer membrane protein antigens of gramnegative bacteria, which can be used to prevent and treat gramnegative bacteria infection in mammals, such as humans; immunology; vaccines |
| 06/15/2010 | US7736859 incubating a sample from humans with monoclonal antibodies or fragments, that specifically binds epitopes of campylobacter antigens, then detecting the formation of antigen-antibody complexes which is indicative of an infection of campylobacter |
| 06/15/2010 | US7736858 Using non-invasive bioassay/immunoassay for differentiating between clinical subtypes of inflammatory bowel disease |
| 06/15/2010 | US7736654 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; humoral or cellular immune response; pancreatic |
| 06/15/2010 | US7736653 Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier |
| 06/15/2010 | US7736652 Comprises immunoglobulin-immunostimulant fusion protein for use in preventing and treating infections, cancer and autoimmune disorders; genetic vaccination; gene therapy |
| 06/15/2010 | US7736649 preventing the viral entry process into target cells, by inhibiting the binding of viral surface glycoprotein to cell surface CD4, to fusion coreceptors CCR5 chemokine receptors and the transient conformation fusion intermediate that ultimately folds into a conformation capable of mediating fusion |
| 06/15/2010 | US7736648 Anti-RSV G protein antibodies |
| 06/15/2010 | US7736646 Methods for modulating angiogenesis with apelin compositions |
| 06/15/2010 | US7736644 Monoclonal antibody for use as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy |